FDA Inspection 1296028 — Adilson Joaquim Westheimer Cavalcante, MD, PhD
The FDA completed an inspection of Adilson Joaquim Westheimer Cavalcante, MD, PhD on December 12, 2025 in Sao Bernardo Do Campo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Sao Bernardo Do Campo (Brazil)
Additional Details
Clinical Investigator (CI)